Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind study evaluating topical Zabalafin hydrogel versus vehicle in adults with mild to moderate atopic dermatitis; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zabalafin hydrogel (zabalafin)

Snippet

Sponsor: Alphyn Biologics | Conditions: Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema | Phase 2 | Status: RECRUITING